Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
ACURA PHARMACEUTICALS, Inc.
(NQ:
ACUR
)
2.040
USD
-0.090 (-4.23%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Press releases about ACURA PHARMACEUTICALS, Inc.
< Previous
1
2
3
4
Next >
Acura Pharmaceuticals Announces First Quarter 2013 Financial Results
May 02, 2013
from
Marketwired News Releases
Analysis Reports on Active Stocks: (NASDAQ:ACUR), (NYSE:SMFG)
April 25, 2013
from
SBWire Direct - Latest Press Releases
Acura Pharmaceuticals to Host First Quarter 2013 Financial Results Conference Call on May 3, 2013
April 22, 2013
from
Marketwired News Releases
Weak Earnings and Oil Falling Push Market Lower as Apple Falls to One Year Low
April 18, 2013
from
PR Newswire
Free Research Reports on ACUR, ALKS, INWK and SCSS Issued by the Bedford Report
April 18, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
Read More
from
Marketwired News Releases
Acura Pharmaceuticals Awarded U.S. Patent for Abuse Deterrent Drug Formulations
April 04, 2013
Further Expands Patent Estate Covering Abuse Deterrent Forms of Opioid Analgesics and Certain Other Active Pharmaceutical Ingredients
Read More
from
Marketwired News Releases
Health Management Associates, Community Health Systems, Elan Corp., and Acura Pharma Under StockCall's Microscope
March 22, 2013
from
PR Newswire
U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous
March 14, 2013
RDInvesting Provides Stocks Research on Acura Pharmaceuticals and Sunesis Pharmaceuticals
Read More
from
Marketwired News Releases
New Partnerships & Brand Loyalty - Research Report on Acura Pharmaceuticals, Élan Corp, Hospira, Alkermes and Valeant
March 08, 2013
from
PR Newswire
Free Research Reports on ACUR, IPXL, SNTS and ASNA Issued by the Bedford Report
March 06, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
Squawk Box Stocks Reports On: Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), Himax Technologies, Inc. (NASDAQ: HIMX), Micron Technology Inc. (NASDAQ: MU), Genworth Financial Inc. (NYSE: GNW)
March 06, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
Read More
from
Marketwired News Releases
Acura Pharmaceuticals Reaches Key Milestone With Entrance Into Chain Drug Store Market
March 05, 2013
KERR DRUG First Chain Drug Store Customer to Stock Nexafed(R) -- Next Generation Cold/Allergy Medicine With Abuse-Deterrent Technology -- Joining the Fight Against Meth Abuse
Read More
from
Marketwired News Releases
Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2012 Financial Results
March 04, 2013
from
Marketwired News Releases
Acura Pharmaceuticals to Present at the Cowen Health Care Conference on March 5, 2013
February 22, 2013
from
Marketwired News Releases
Free Research Reports on ACUR, BBG, MBI and TBI Issued by the Bedford Report
February 07, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
Read More
from
Marketwired News Releases
Mergers and Acquisitions on the Rise in 2013 as Big Pharma Companies Hold Record Amounts of Cash on Hand
February 07, 2013
Five Star Equities Provides Stock Research on Acura Pharmaceuticals and Protalix BioTherapeutics
Read More
from
Marketwired News Releases
The Real Story Behind ACUR, DSTI, CSUN and DYSL
December 27, 2012
from
Marketwired News Releases
Acura Pharmaceuticals, Inc. Submits Investigational New Drug Application
December 20, 2012
Request to Commence Clinical Investigation
Read More
from
Marketwired News Releases
Our Pros Knew CPWR, TROX, ACUR and CBOU Would Be Top Gainers on Monday
December 18, 2012
from
Marketwired News Releases
Top Stock Movers: Molycorp, Inc. (NYSE: MCP), BG Medicine, Inc. (NASDAQ: BGMD), Acura Pharmaceuticals Inc. (NASDAQ: ACUR), Psychic Friends Network Inc. (OTCQB: PFNI)
December 12, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
Read More
from
Marketwired News Releases
Stearns Research Smart Scan Trades for 12/13/2012: Biotech Stocks
December 12, 2012
from
SBWire Direct - Latest Press Releases
Strategy Behind Our Success, We Get in Early: ACUR, SOMX, BGMD and DNDN
December 12, 2012
from
Marketwired News Releases
End of Day Trend Analysis Reports: (NASDAQ: ACUR), (NYSE: LNC)
December 11, 2012
from
SBWire Direct - Latest Press Releases
Free Research Reports on ACUR, BIIB, HON and MCP Issued by the Bedford Report
December 11, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit
Read More
from
Marketwired News Releases
Acura Pharmaceuticals Launches Next Generation Cold Medicine to Aid in the Fight Against Meth
December 10, 2012
Nexafed(R)'s Abuse-Deterrent Technology Disrupts Conversion of Pseudoephedrine to Dangerous Illegal Drug Methamphetamine Without Compromising Effective Nasal-Congestion Relief
Read More
from
Marketwired News Releases
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012
November 30, 2012
Five Star Equities Provides Stock Research on Acura Pharmaceuticals and DARA Biosciences
Read More
from
Marketwired News Releases
Free Research Reports on ACUR, BKS, IQNT and LQDT Issued by the Bedford Report
November 30, 2012
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
Read More
from
Marketwired News Releases
Acura Pharmaceuticals Announces Successful Bioequivalent Study for NEXAFED
November 20, 2012
from
Marketwired News Releases
Acura Pharmaceuticals Announces Third Quarter 2012 Financial Results
November 06, 2012
from
Marketwired News Releases
Acura Pharmaceuticals to Host Third Quarter 2012 Financial Results Conference Call on November 7, 2012
November 01, 2012
from
Marketwired News Releases
< Previous
1
2
3
4
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here